SCHEMBL1957182

SCHEMBL1957182

CC1(C)CCC(CN2CCN(c3ccc(C(=O)N[S+]([O-])c4ccc(OCC5(F)CCOCC5)c([N+](=O)[O-])c4)c(Oc4cc(F)cc5[nH]ncc45)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 7/20 0.64
▸ BCL2L1 Q07817 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1957183 0.91 BCL2 (0.77) BCL2BCL2L1
SCHEMBL1955671 0.87 BCL2 (0.83) BCL2
SCHEMBL1958179 0.83 BCL2 (0.59) BCL2
SCHEMBL1958953 0.83 BCL2 (0.78) BCL2
SCHEMBL1958659 0.82 BCL2 (0.79) BCL2
SCHEMBL1959045 0.81 BCL2 (0.83) BCL2
SCHEMBL1957665 0.81 BCL2 (0.69) BCL2
SCHEMBL1956040 0.80 BCL2 (0.71) BCL2
SCHEMBL17796027 0.80 BCL2 (0.66) BCL2BCL2L1
SCHEMBL1958125 0.79 BCL2 (0.82) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507211-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2012-10-10 — — EP disclosed
WO-2011068560-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-06-09 — — WO disclosed
Send feedback